Aprio Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Aprio Wealth Management's NVS Position: Q3 2026 in Review
Aprio Wealth Management reduced its Novartis (NVS) stake by 10% in Q3 2026, selling an estimated $130K and leaving 7,659 shares worth $1.09M. The position accounts for 0.05% of the portfolio, ranked #235.
Aprio Wealth Management first reported a position in NVS in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.33M in Q2 2026. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Aprio Wealth Management held 7,659 shares of Novartis worth $1.09M as of Q3 2026.
- Aprio Wealth Management sold 854 Novartis shares in Q3 2026, an estimated $130K.
- Novartis made up 0.05% of Aprio Wealth Management's portfolio in Q3 2026, its #235 holding.
- Aprio Wealth Management first reported a position in Novartis in Q3 2024 and has held it in 8 quarters since.
- Aprio Wealth Management's Novartis position peaked at $1.33M in Q2 2026.
- 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Aprio Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.